Two years after pharma company Bayer first agreed to purchase GMO and pesticide Goliath Monsanto, European regulators have given their seal of approval to the deal. […]
NEWS Bayer is facing a second U.S. jury over allegations that its glyphosate-based weed killer Roundup causes cancer. The trial follows only six months after the […]
NEWS With Bayer now facing over 11 thousand lawsuits in the United States over the weed killer Roundup and its active ingredient glyphosate, Bayer boss Werner […]
NEWS Bayer and Janssen, the pharmaceutical companies behind the blood thinner Xarelto, have reached a $775 million settlement in 25 thousand lawsuits alleging patients were not […]
The Monsanto takeover in 2018 promised big business for Bayer. At a time of intense pressure on pharmaceutical companies, the strengthening of Bayer’s agrichemical division seemed […]
NEWS Drug company Bayer, which bought Monsanto last summer, says it is making scientific studies available for public scrutiny. It is trying to counter growing concerns about […]
On Thursday 4 April 2019, our Foundation published an article describing how, due to the growing problems following Bayer’s takeover of Monsanto, the company’s situation could […]
Bayer’s takeover of Monsanto reportedly gets clearance in the United States
NEWS The Wall Street Journal reports that the U.S. Department of Justice has decided to approve Bayer’s $66-billion takeover of Monsanto, thus removing the last major […]